Gabapentin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
81033-123 -
Package NDC
81033-123-44 -
Application number
ANDA091286 -
SPL ID
3f2ba3d6-6087-eaf2-e063-6294a90a7642 -
SPL set ID
3f2ba3d6-6086-eaf2-e063-6294a90a7642 -
UNII
6CW7F3G59X -
RxCUI
283523
What the source publishes
- Labeler
- Kesin Pharma Corporation
- Active ingredients
- Gabapentin
- Form
- SOLUTION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Gabapentin",
"splId": "3f2ba3d6-6087-eaf2-e063-6294a90a7642",
"labels": [
{
"setId": "3f2ba3d6-6086-eaf2-e063-6294a90a7642",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f2ba3d6-6086-eaf2-e063-6294a90a7642",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3f2ba3d6-6086-eaf2-e063-6294a90a7642"
}
],
"routes": [
"ORAL"
],
"labeler": "Kesin Pharma Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "40 CUP, UNIT-DOSE in 1 CARTON (81033-123-44) / 5 mL in 1 CUP, UNIT-DOSE (81033-123-05)",
"package_ndc": "81033-123-44",
"identifierStatus": "well-formed",
"marketing_start_date": "20250901"
}
],
"productId": "81033-123_3f2ba3d6-6087-eaf2-e063-6294a90a7642",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "81033-123",
"deaSchedule": null,
"genericName": "Gabapentin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "GABAPENTIN",
"strength": "50 mg/mL"
}
],
"applicationNumber": "ANDA091286",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250806",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"unii": [
"6CW7F3G59X"
],
"rxcui": [
"283523"
],
"spl_set_id": [
"3f2ba3d6-6086-eaf2-e063-6294a90a7642"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"Kesin Pharma Corporation"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:81033-123_3f2ba3d6-6087-eaf2-e063-6294a90a7642"